17 June 2019

Meet us at the 2019 ASCO annual meeting in Chicago

Jeremy BASTID, Chief Operating Officer, will attend the ASCO annual meeting to be held in Chicago, IL, May 31 – June 4, 2019.
17 November 2018

Meet us at the 2018 Bio Europe meeting in Copenhagen

Gilles Alberici, CEO, will attend the 2018 BIO-Europe meeting to be held in Copenhagen on November 2018, 5th to 7th.
27 October 2018

PRESS RELEASE – IL-17 patent granted in Europe

Press Release Lyon, October 8, 2018 Interleukin-17 patent granted in Europe Lyon, France, October 8, 2018 – OREGA Biotech, the biotech company committed to the development of novel monoclonal antibody-based immunotherapy for cancer patients, announced the grant of patent EP2569335 by the European Patent Office. This patent covers IL-17A neutralizing antibodies for use as a therapeutic tool to increase the response to other chemotherapeutic agents. “The delivery of this European Patent is another important milestone for OREGA Biotech; it is the fifth issued patent related to our IL‑17 programs”, commented Jeremy Bastid, Chief Operating Officer of OREGA Biotech. “Intellectual property is a key asset in OREGA’s target discovery programs. Our capacity to obtain broad claims covering novel cancer targets offers a valuable competitive advantage.” Read the press release.
23 October 2018

AstraZeneca and Innate Pharma enter into partnership for the development of CD39 mAbs

On October 23, 2018, Innate Pharma announced that it had entered into a development collaboration and option for further co-development and co-commercialisation with AstraZeneca for its CD39 monoclonal antibody, IPH5201.
AstraZeneca and Innate Pharma enter into partnership for the development of CD39 mAbs
This website uses cookies to improve your experience. By using this website you agree to our Data Protection Policy.
Read more